Hepatocyte growth factor (HGF) stimulates survival, proliferation (1), adhesion (2) and migration (3) of malignant plasma cells and is a potential contributor to the bone disease of multiple myeloma (4). This evidence concerns the gene HGF and plasma cell myeloma.